These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23607751)

  • 1. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
    Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
    Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
    Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Check-control of inflammation displayed by bone marrow mesenchymal stem cells in rheumatoid arthritis patients.
    Lamas JR; Mucientes A; Lajas C; Fernández-Gutiérrez B; Lópiz Y; Marco F; Jover JA; Abásolo L; Rodriguez-Rodriguez L
    Immunotherapy; 2019 Sep; 11(13):1107-1116. PubMed ID: 31378114
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.
    Radstake TR; van Bon L; Broen J; Wenink M; Santegoets K; Deng Y; Hussaini A; Simms R; Cruikshank WW; Lafyatis R
    PLoS One; 2009 Jun; 4(6):e5981. PubMed ID: 19543397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
    Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
    Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.
    Saldanha-Araujo F; Haddad R; Farias KC; Souza Ade P; Palma PV; Araujo AG; Orellana MD; Voltarelli JC; Covas DT; Zago MA; Panepucci RA
    J Cell Mol Med; 2012 Jun; 16(6):1232-44. PubMed ID: 21777379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29c-3p promotes senescence of human mesenchymal stem cells by targeting CNOT6 through p53-p21 and p16-pRB pathways.
    Shang J; Yao Y; Fan X; Shangguan L; Li J; Liu H; Zhou Y
    Biochim Biophys Acta; 2016 Apr; 1863(4):520-32. PubMed ID: 26792405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.
    Cipriani P; Di Benedetto P; Ruscitti P; Campese AF; Liakouli V; Carubbi F; Pantano I; Berardicurt O; Screpanti I; Giacomelli R
    Arthritis Res Ther; 2014 Sep; 16(5):442. PubMed ID: 25248297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Tolerance of Human Dental Pulp-Derived Mesenchymal Stem Cells Mediated by CD4⁺CD25⁺FoxP3⁺ Regulatory T-Cells and Induced by TGF-β1 and IL-10.
    Hong JW; Lim JH; Chung CJ; Kang TJ; Kim TY; Kim YS; Roh TS; Lew DH
    Yonsei Med J; 2017 Sep; 58(5):1031-1039. PubMed ID: 28792150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells.
    Ho PJ; Yen ML; Tang BC; Chen CT; Yen BL
    Antioxid Redox Signal; 2013 May; 18(15):1895-905. PubMed ID: 23088254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway.
    Zhang DY; Wang HJ; Tan YZ
    PLoS One; 2011; 6(6):e21397. PubMed ID: 21712954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine.
    Cipriani P; Marrelli A; Benedetto PD; Liakouli V; Carubbi F; Ruscitti P; Alvaro S; Pantano I; Campese AF; Grazioli P; Screpanti I; Giacomelli R
    Angiogenesis; 2013 Jul; 16(3):595-607. PubMed ID: 23413114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NANOG has a role in mesenchymal stem cells' immunomodulatory effect.
    Sun Z; Han Q; Zhu Y; Li Z; Chen B; Liao L; Bian C; Li J; Shao C; Zhao RC
    Stem Cells Dev; 2011 Sep; 20(9):1521-8. PubMed ID: 21235326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
    Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells.
    Minieri V; Saviozzi S; Gambarotta G; Lo Iacono M; Accomasso L; Cibrario Rocchietti E; Gallina C; Turinetto V; Giachino C
    J Cell Mol Med; 2015 Apr; 19(4):734-43. PubMed ID: 25619736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue.
    Sineh Sepehr K; Razavi A; Hassan ZM; Fazel A; Abdollahpour-Alitappeh M; Mossahebi-Mohammadi M; Yekaninejad MS; Farhadihosseinabadi B; Hashemi SM
    Cancer Immunol Immunother; 2020 Sep; 69(9):1841-1854. PubMed ID: 32350594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells.
    Li XY; Ding J; Zheng ZH; Li XY; Wu ZB; Zhu P
    Mol Med Rep; 2012 Nov; 6(5):1183-9. PubMed ID: 22923041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.
    Kronsteiner B; Wolbank S; Peterbauer A; Hackl C; Redl H; van Griensven M; Gabriel C
    Stem Cells Dev; 2011 Dec; 20(12):2115-26. PubMed ID: 21381973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.